{"id":"https://openalex.org/W2135577396","doi":"https://doi.org/10.1086/343746","title":"The Safety of Voriconazole","display_name":"The Safety of Voriconazole","alternate_titles":[],"publication_year":2002,"publication_date":"2002-11-05","ids":{"openalex":"https://openalex.org/W2135577396","doi":"https://doi.org/10.1086/343746","mag":"2135577396","pmid":"https://pubmed.ncbi.nlm.nih.gov/12410490"},"language":"en","primary_location":{"id":"doi:10.1086/343746","doi":"https://doi.org/10.1086/343746","is_oa":false,"landing_page_url":"https://doi.org/10.1086/343746","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2135577396"],"child_works_count":0,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039242377","display_name":"Brian A. Potoski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brian\u00a0A. Potoski","raw_affiliation_strings":["Department of Pharmacy, The Ohio State University Medical Center, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The Ohio State University Medical Center, Columbus, Ohio","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110886497","display_name":"Jack E Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jack Brown","raw_affiliation_strings":["Department of Pharmacy, The Ohio State University Medical Center, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The Ohio State University Medical Center, Columbus, Ohio","institution_ids":["https://openalex.org/I2802841970"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110886497"],"corresponding_institution_ids":["https://openalex.org/I2802841970"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":93,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"10","first_page":"1273","last_page":"1275"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.9279999732971191},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7200000286102295},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.5170000195503235},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.8299999833106995},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.8769999742507935},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.7099999785423279},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5989999771118164},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.3070000112056732},{"id":"https://openalex.org/keywords/liposomal-amphotericin-b","display_name":"liposomal amphotericin B","score":0.7979999780654907},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.6710000038146973},{"id":"https://openalex.org/keywords/esophageal-candidiasis","display_name":"esophageal candidiasis","score":0.9150000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9339384436607361},{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.8006434440612793},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32311517000198364},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.23889073729515076},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.07652232050895691}],"mesh":[{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001228","descriptor_name":"Aspergillosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008111","descriptor_name":"Liver Function Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016867","descriptor_name":"Immunocompromised Host","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1086/343746","doi":"https://doi.org/10.1086/343746","is_oa":false,"landing_page_url":"https://doi.org/10.1086/343746","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:12410490","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12410490","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Comment"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1596948422","https://openalex.org/W1964720826","https://openalex.org/W1986100989","https://openalex.org/W2027962943","https://openalex.org/W2029714817","https://openalex.org/W2058668950","https://openalex.org/W2082695689","https://openalex.org/W2136517919"],"related_works":["https://openalex.org/W2062355274","https://openalex.org/W1972884399","https://openalex.org/W2139365607","https://openalex.org/W4413614728","https://openalex.org/W4313485003","https://openalex.org/W2918445507","https://openalex.org/W4323042656","https://openalex.org/W4382316721","https://openalex.org/W2647588694","https://openalex.org/W4220884718"],"abstract_inverted_index":{"Sir\u2014We":[0],"read":[1],"with":[2,68,138,172,183,223,323,378,387,399,459,681,691,755,797],"interest":[3],"the":[4,17,52,69,92,129,135,154,176,196,281,284,293,295,308,318,329,362,372,420,429,433,501,507,518,522,529,575,629,682,716,748,756],"article":[5],"by":[6,432,496],"Denning":[7,27,666,692],"et":[8,162,190,498,570,667,693],"al.":[9,163,191,499,571,668,694],"entitled":[10],"\u201cEfficacy":[11],"and":[12,28,87,123,261,326,407,436,454,490,513,534,542,613,622,662,726],"Safety":[13],"of":[14,19,37,55,77,91,134,141,143,157,178,185,199,233,253,283,292,297,337,374,416,419,445,469,503,509,524,531,545,587,609,631,633,657,659,674,676,684,715,758,777],"Voriconazole":[15,402],"in":[16,66,175,230,235,250,255,367,428,528,547,552,579,601,638,641,761],"Treatment":[18],"Acute":[20],"Invasive":[21],"Aspergillosis\u201d":[22],"[1].":[23],"In":[24,127,153,216,422,493,559,753],"their":[25,778],"study,":[26],"colleagues":[29,535],"reported":[30,109,229,249,412,573],"adverse":[31,221],"events":[32],"that":[33,75,88,99,110,132,166,195,385,461,473,517,537,543,574,600,628,671,696,707,793],"indicate":[34],"an":[35,217,289,652,736,762],"area":[36,520],"concern.":[38],"Specifically,":[39],"20":[40,79],"patients":[41,80,94,112,137,207,304,322,332,553,770,783],"(14.6%)":[42],"developed":[43,146],"abnormal":[44,96,147,663],"liver":[45,148,151,664],"function":[46,149,299],"values":[47,98],"(>3":[48],"or":[49,150,343,467,788],"5":[50,90,614],"times":[51],"upper":[53],"limit":[54],"normal).":[56],"As":[57],"a":[58,240,358,413,494,560,585,708],"result,":[59],"therapy":[60,342],"was":[61,169,511,515,597],"discontinued":[62],"for":[63,213,242,271,353,476,566,721,744,769,782],"these":[64,78,470,477],"patients,":[65,237,568],"accordance":[67],"study":[70,156,495],"protocol.":[71],"The":[72,106,258],"authors":[73,107,130],"indicated":[74],"11":[76,93],"had":[81,95,113,118,125],"received":[82,334,582,605],"hematopoietic":[83],"stem":[84],"cell":[85],"transplants":[86],"only":[89],"laboratory":[97,227,247],"were":[100],"attributed":[101],"to":[102,159,206,219,288,328,364,686,701,711,723],"another":[103,347],"disease":[104],"process.":[105],"also":[108,193],"some":[111,117,124,408],"elevated":[114,119],"transaminase":[115],"levels,":[116,122],"alkaline":[120],"phosphatase":[121],"both.":[126],"addition,":[128,423,754],"stated":[131,194],"6":[133],"22":[136],"plasma":[139,577,593,618],"concentrations":[140,418,544,656,673,714],"voriconazole":[142,158,167,234,254,272,379,400,424,455,504,583,606,634,658,675,734,774],">6000":[144,660],"ng/mL":[145,621,661,678],"failure.":[152],"largest":[155],"date,":[160],"Walsh":[161,189,569],"[2]":[164,192],"concluded":[165],"use":[168,184,380,505],"not":[170,204,382,482,647],"associated":[171,377,386,398],"any":[173],"increase":[174],"frequency":[177],"hepatic":[179,226,298,478,786],"abnormalities,":[180],"as":[181,340,351,463,775],"compared":[182],"liposomal":[186],"amphotericin":[187,338,344],"B.":[188],"low":[197],"rates":[198],"hepatotoxicity":[200,745],"they":[201],"noted":[202,670],"may":[203,394,635,650,740,772,794],"pertain":[205],"who":[208,313,333,441,554,581,604,771,784,789],"are":[209,442,449,474,481,555,679,790],"receiving":[210,451],"prolonged":[211],"treatment":[212,352],"proven":[214],"infection.":[215],"effort":[218],"compare":[220],"events,":[222],"emphasis":[224],"on":[225,275,506],"abnormalities":[228,248,301],"clinical":[231,251,409],"trials":[232,252,410],"immunocompromised":[236,256],"we":[238,705],"compiled":[239],"table":[241],"review":[243,291],"(table":[244],"1).":[245],"Hepatic":[246],"patients.":[257],"US":[259],"Food":[260],"Drug":[262],"Administration":[263],"(FDA)":[264],"Antiviral":[265],"Drugs":[266,472],"Advisory":[267],"Committee's":[268],"briefing":[269],"document":[270],"adds":[273],"insight":[274],"this":[276,759],"subject":[277],"[8].":[278,391],"It":[279],"is":[280,305,381,425,646,735],"opinion":[282],"committee":[285,363],"that,":[286,366,732],"according":[287],"overall":[290],"data,":[294],"incidence":[296,309,319,330],"test":[300],"among":[302,310,320,331],"voriconazole-treated":[303],"greater":[306,316,383,637],"than":[307,317,384,599,640,746],"healthy":[311],"volunteers":[312,603],"receive":[314,773],"placebo,":[315],"fluconazole-treated":[321],"esophageal":[324],"candidiasis,":[325],"similar":[327],"lipid":[335],"formulations":[336],"B":[339,345],"empirical":[341],"plus":[346],"licensed":[348],"antifungal":[349,389],"agent":[350],"acute":[354],"invasive":[355,687],"aspergillosis.":[356,688],"Furthermore,":[357,704],"literature":[359],"comparison":[360],"led":[361],"conclude":[365],"equivalent,":[368],"severely":[369],"ill":[370],"populations,":[371],"risk":[373,444],"hepatotoxic":[375],"reactions":[376],"other":[388],"therapies":[390],"However,":[392],"there":[393,649],"be":[395,540,549,636,651,702,719,767],"considerable":[396],"challenges":[397,565],"therapy.":[401],"exhibits":[403],"nonlinear":[404],"pharmacokinetics":[405,508],"[6],":[406],"have":[411,741,785],"wide":[414],"range":[415],"serum":[417,655,672,713],"drug.":[421],"extensively":[426],"metabolized":[427],"liver,":[430],"mainly":[431],"CYP2C9,":[434],"CYP2C19,":[435],"CYP3A4":[437],"isoenzymes":[438],"[9].":[439],"Patients":[440],"at":[443,584,607],"acquiring":[446],"fungal":[447],"infections":[448],"typically":[450],"multiple":[452],"medications,":[453],"could":[456],"potentially":[457,795],"interact":[458,796],"drugs":[460],"act":[462],"either":[464],"substrates,":[465],"inhibitors,":[466],"inducers":[468],"isoenzymes.":[471],"substrates":[475],"enzymes":[479],"include\u2014but":[480],"limited":[483],"to\u2014diazepam,":[484],"cyclosporine,":[485],"diltiazem,":[486],"tacrolimus,":[487],"verapamil,":[488],"sulfamethoxazole,":[489],"phenytoin":[491],"[10].":[492],"Romero":[497,533],"[3],":[500],"effect":[502],"cyclosporine":[510,525,538,546],"evaluated,":[512],"it":[514,645,739],"found":[516],"mean":[519],"under":[521],"curve":[523],"increased":[526],"1.7-fold":[527],"presence":[530],"voriconazole.":[532,558,798],"recommended":[536],"doses":[539],"halved":[541],"blood":[548],"carefully":[550],"monitored":[551],"concomitantly":[556],"administered":[557],"look":[561],"toward":[562],"potential":[563,743],"dosing":[564],"younger":[567],"[4]":[572],"median":[576],"concentration":[578],"children":[580,639],"dosage":[586],"\u2a7e4":[588],"mg/kg":[589,611,615],"iv":[590],"b.i.d.":[591,612,616],"(median":[592,617],"concentration,":[594],"1566":[595],"ng/mL)":[596],"lower":[598],"adult":[602],"dosages":[608],"4":[610],"concentrations,":[619],"5671":[620],"7404":[623],"ng/mL,":[624],"respectively),":[625],"which":[626],"suggests":[627],"rate":[630],"clearance":[632],"adults.":[642],"Also,":[643],"although":[644,733],"certain,":[648],"association":[653],"between":[654],"function.":[665],"[1]":[669,695],">250":[677],"consistent":[680],"threshold":[683],"response":[685],"We":[689],"agree":[690],"dose":[697],"modification":[698],"guidelines":[699],"need":[700],"developed.":[703],"believe":[706],"validated":[709],"assay":[710],"determine":[712],"drug":[717,760],"should":[718,730],"available":[720,750],"clinicians":[722],"ensure":[724],"efficacy":[725],"prevent":[727],"toxicity.":[728],"Clinicians":[729],"recognize":[731],"azole":[737,751],"antifungal,":[738],"more":[742],"do":[747],"previously":[749],"antifungals.":[752],"availability":[757],"oral":[763],"form,":[764],"caution":[765],"must":[766],"exercised":[768],"part":[776],"outpatient":[779],"regimen,":[780],"especially":[781],"insufficiency":[787],"taking":[791],"medications":[792]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2135577396","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
